Cryno is developing a novel GLP-1 agonist for treatment and prevention of peripheral neuropathy and management of type 2 Diabetes and its complications.
Company Details
- Founded
- -
- Address
- Skolkovo Innovation Center, Bolshoi Blvd 42-1,office 332,russian Federation
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://cryno.bio/
- HQ
- Moscow
Cryno Questions
Cryno's website is http://cryno.bio/
Cryno's LinkedIn profile is https://ru.linkedin.com/company/cryno
Cryno's industry is
Biotechnology Research
Cryno's top competitors are
Gero,
Longevity Economics Institute,
Oneful Health Inc,
Phyteau, Inc.,
Medmark Usa,
Metabolytic Research,
Viva City,
Gray Matter,
Synergic Bio Solutions,
Alfa Chem.
Cryno's categories are Biotechnology Research
Cryno's founding year is 2016
